Cargando…

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression

Brain-derived neurotrophic factor (BDNF) is a growth factor synthesized in the cell bodies of neurons and glia, which affects neuronal maturation, the survival of nervous system, and synaptic plasticity. BDNF play an important role in the pathophysiology of major depression (MD). The serum BDNF leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Reiji, Okamoto, Naomichi, Chibaatar, Enkmurun, Natsuyama, Tomoya, Ikenouchi, Atsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953440/ https://www.ncbi.nlm.nih.gov/pubmed/36831119 http://dx.doi.org/10.3390/biomedicines11020584

Ejemplares similares

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder
por: Chibaatar, Enkhmurun, et al.
Publicado: (2023)

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
por: Okamoto, Naomichi, et al.
Publicado: (2022)

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022)

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression
por: Tesen, Hirofumi, et al.
Publicado: (2022)

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls
por: Fujii, Rintaro, et al.
Publicado: (2022)

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
por: Hoshikawa, Takashi, et al.
Publicado: (2022)

Prolonged delirium caused by lithium poisoning in an endometrial cancer patient at advanced stage: A case report
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
por: Okamoto, Naomichi, et al.
Publicado: (2020)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Major depression with musical obsession treated with vortioxetine: a case report
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression
por: Ikenouchi, Atsuko, et al.
Publicado: (2023)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
por: Ikenouchi, Atsuko, et al.
Publicado: (2022)

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2020)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study
por: Seki, Issei, et al.
Publicado: (2023)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Estimation of subjective quality of life in schizophrenic patients using speech features
por: Shibata, Yuko, et al.
Publicado: (2023)

Corrigendum: Estimation of subjective quality of life in schizophrenic patients using speech features
por: Shibata, Yuko, et al.
Publicado: (2023)

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study
por: Nguyen, LeHoa, et al.
Publicado: (2020)

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report
por: Katsumura, Tetsuya, et al.
Publicado: (2022)

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder
por: Katsuki, Asuka, et al.
Publicado: (2020)

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
por: Ikenouchi-Sugita, Atsuko, et al.
Publicado: (2008)

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression
por: Ueda, Masashi, et al.
Publicado: (2020)

A case of severe paraneoplastic itch resistant to antihistamines and responding to serotonin reuptake inhibitors
por: Werda, Ines, et al.
Publicado: (2021)

The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains
por: Ueda, Issei, et al.
Publicado: (2020)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g38sm6mv9mg763bs0qjletbila